Deep breathing exercises slow the heart rate and promote relaxation, while progressive muscle relaxation involves tensing and then releasing different muscle groups to alleviate physical tension
GLP-1 receptor agonists may be considered when additional treatment goals include weight reduction, improved glycemic control, chronic kidney disease risk reduction, or lowering atherosclerotic cardiovascular risk, particularly in patients with obesity or established Atherosclerotic Cardiovascular Disease (ASCVD) [7, 16, 47]
Research also suggests it plays a regulatory role in the hypothalamicpituitaryadrenal (HPA) axis, helping to support balanced cortisol rhythms and a more adaptive stress response
Iodide kinetic studies showed rapid turnover of thyroid iodide and production of excess quantities of plasma butanol-insoluble iodine
The FDA approved the first GLP-1 agonist, exenatide, to treat type 2 diabetes in 2005